Correlation between pre-existing MEK1(P124) mutations and clinical and in vitro response to BRAF inhibitors in metastatic melanoma

Matteo S. Carlino, Carina Fung, Hamideh Shahheydari, Jason R. Todd, Richard A. Scolyer, Richard Kefford, Georgina V. Long, Helen Rizos

    Research output: Contribution to journalMeeting abstract

    Original languageEnglish
    Pages (from-to)9004-9004
    Number of pages1
    JournalJournal of Clinical Oncology
    Issue number15 supplement
    Publication statusPublished - 20 May 2014
    Event50th Annual Meeting of the American-Society-of-Clinical-Oncology - Chicago, United States
    Duration: 30 May 20143 Jun 2014

    Cite this